TimesSquare Capital Management LLC Has $107.72 Million Stock Holdings in Chemed Co. (NYSE:CHE)

TimesSquare Capital Management LLC decreased its stake in shares of Chemed Co. (NYSE:CHE) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 184,210 shares of the company’s stock after selling 19,300 shares during the period. Chemed comprises about 1.6% of TimesSquare Capital Management LLC’s investment portfolio, making the stock its 8th biggest holding. TimesSquare Capital Management LLC owned about 1.22% of Chemed worth $107,717,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC acquired a new position in Chemed in the fourth quarter valued at approximately $37,000. Larson Financial Group LLC acquired a new stake in Chemed in the third quarter worth $44,000. SRS Capital Advisors Inc. lifted its stake in Chemed by 110.6% in the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock valued at $58,000 after buying an additional 52 shares during the last quarter. Covestor Ltd boosted its holdings in shares of Chemed by 27.4% during the third quarter. Covestor Ltd now owns 144 shares of the company’s stock valued at $75,000 after acquiring an additional 31 shares during the period. Finally, ORG Partners LLC bought a new position in shares of Chemed during the third quarter worth about $126,000. 95.85% of the stock is owned by institutional investors.

Chemed Stock Up 0.2 %

Chemed stock traded up $1.42 during mid-day trading on Thursday, hitting $574.13. The company’s stock had a trading volume of 96,395 shares, compared to its average volume of 81,448. Chemed Co. has a twelve month low of $492.84 and a twelve month high of $654.62. The stock has a market capitalization of $8.69 billion, a P/E ratio of 30.80, a P/E/G ratio of 2.29 and a beta of 0.46. The stock’s fifty day moving average price is $618.69 and its two-hundred day moving average price is $594.39.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). Chemed had a net margin of 12.36% and a return on equity of 30.52%. The firm had revenue of $589.23 million for the quarter, compared to analysts’ expectations of $587.18 million. Equities analysts expect that Chemed Co. will post 21.72 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.28%. The ex-dividend date was Friday, February 23rd. Chemed’s dividend payout ratio is currently 8.61%.

Insider Buying and Selling

In other Chemed news, VP Brian C. Judkins sold 11,158 shares of Chemed stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the transaction, the vice president now directly owns 1,422 shares of the company’s stock, valued at approximately $917,190. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the company’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the transaction, the vice president now owns 1,422 shares of the company’s stock, valued at approximately $917,190. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the sale, the executive vice president now directly owns 20,760 shares in the company, valued at approximately $13,320,654. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,808 shares of company stock valued at $10,184,531. Insiders own 3.32% of the company’s stock.

Analyst Ratings Changes

CHE has been the subject of several recent analyst reports. Royal Bank of Canada upped their target price on shares of Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a research report on Monday, March 4th. Oppenheimer lifted their target price on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Thursday, February 29th. Finally, StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.